StockNews.AI
HIMS
StockNews.AI
23 days

Hims & Hers Health, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds HIMS Investors of Important Lead Plaintiff Deadline on August 25, 2025

1. A class action lawsuit has been filed against Hims & Hers Health, Inc. 2. Allegations include misleading statements about the company's business practices. 3. Concerns raised over the safety of Hims & Hers' products. 4. Potential termination of collaboration with Novo Nordisk is a risk. 5. Lead plaintiff deadline set for August 25, 2025.

6m saved
Insight
Article

FAQ

Why Very Bearish?

The lawsuit alleges significant misconduct which can severely damage investor confidence, similar to past cases like those against Theranos. Any potential termination of key collaborations, like with Novo Nordisk, could significantly affect future revenues.

How important is it?

The news indicates potential financial liability for Hims & Hers, affecting stock prices and investor behavior. Given the high severity of the allegations, it is crucial for stakeholders.

Why Short Term?

Given the immediacy of the class action filings, investor sentiment will likely react swiftly to news developments. As seen in other cases of class actions, stock can drop sharply in response to legal issues.

Related Companies

NVDCELANRHHBY
, /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) on behalf of those who purchased or otherwise acquired Hims & Hers securities between April 29, 2025, and June 23, 2025, inclusive (the "Class Period"). The lead plaintiff deadline is August 25, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:If you suffered Hims & Hers losses, you may CLICK HERE or copy and paste the following link into your browser: https://www.ktmc.com/new-cases/hims-hers-health-inc?utm_source=PR_Newswire&utm_medium=PR You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected].  DEFENDANTS' ALLEGED MISCONDUCT:The complaints allege that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Hims & Hers was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk;" (2) as a result, there was a substantial risk that Hims & Hers' collaboration with Novo Nordisk would be terminated; and (3) that, as a result of the foregoing, Defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Please CLICK HERE to view our video or copy and paste this link into your browser: https://youtu.be/xuStgUOFgE8 THE LEAD PLAINTIFF PROCESS:Hims & Hers investors may, no later than August 25, 2025, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. Kessler Topaz Meltzer & Check, LLP encourages Hims & Hers investors who have suffered significant losses to contact the firm directly to acquire more information. CLICK HERE TO SIGN UP FOR THE CASE OR GO TO: https://www.ktmc.com/new-cases/hims-hers-health-inc?utm_source=PR_Newswire&utm_medium=PR  ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP: Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.  The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com. CONTACT:Kessler Topaz Meltzer & Check, LLPJonathan Naji, Esq.(484) 270-1453280 King of Prussia RoadRadnor, PA 19087[email protected]  May be considered attorney advertising in certain jurisdictions.  Past results do not guarantee future outcomes. SOURCE Kessler Topaz Meltzer & Check, LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News